1.27
price down icon3.79%   -0.05
after-market Dopo l'orario di chiusura: 1.33 0.06 +4.72%
loading

Nrx Pharmaceuticals Inc Azioni (NRXP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
36.13%
5.998
4.406 5.808 8.188 9.435
Interest Income/Expense
187.50%
0.23
0.08 0.04 - -
Operating Income/Loss
36.13%
-5.998
-4.406 -5.808 -8.188 -9.435
Nonoperating Income/Loss
816.22%
-0.53
0.074 -0.254 -0.529 -1.604
Income/Loss From Continuing Operations Before Tax
50.69%
-6.528
-4.332 -6.062 -8.717 -11.04
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
50.69%
-6.528
-4.332 -6.062 -8.717 -11.04
Net Income/Loss
50.69%
-6.528
-4.332 -6.062 -8.717 -11.04
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
437.29%
8.8523
1.6476 81.95 73.22 67.45
Diluted Average Shares
8.8523
- 81.95 73.22 67.45
Basic Earnings Per Share
1,380%
-0.74
-0.05 -0.07 -0.12 -0.16
Diluted Earnings Per Share
-0.74
- -0.07 -0.12 -0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):